• Product NameVidarabine
• Brief DescriptionInhibitors
• Purification99.91%
• Biological ActivityVidarabine is an antiviral drug which is active against herpes simplex and varicella zoster viruses.
• Target NameDNA/RNA Synthesis inhibitor; Tyrosine Kinases
• CAS No. 5536-17-4
• Calculated MW 267.24
• Formulation C10H13N5O4
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Immunology
  SMILES:C1=NC2=C(C(=N1)N)N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O
  Pathways:DNA Damage/DNA Repair; Proteases/Proteasome
  Receptor:DNA polymerase; DNA polymerase; Tyrosine Kinases
  Boling pt:676.3C
  Melting pt:260-265C?
  Solubility:Water: 3 mg/mL (11.22 mM); DMSO: 53 mg/mL (198.32 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Suzuki M, et al. Antiviral Res. 2006 Nov; 72(2):157-61.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting